(2014). Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling.
Chicago Style (17th ed.) CitationTemozolomide Down-regulates P-glycoprotein in Human Blood-brain Barrier Cells by Disrupting Wnt3 Signaling. 2014.
MLA (8th ed.) CitationTemozolomide Down-regulates P-glycoprotein in Human Blood-brain Barrier Cells by Disrupting Wnt3 Signaling. 2014.
Warning: These citations may not always be 100% accurate.